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Nonpsychotic anomalies of subjective experience were em-
phasized in both classic literature and phenomenological
psychiatry as essential clinical features of schizophrenia.
However, only in recent years, their topicality with respect
to the construct validity of the concept of the schizophrenia
spectrum has been explicitly acknowledged, mainly as
a consequence of the increasing focus on early detection
and prevention of psychosis. The current study tested the
hypothesis of a speciﬁc aggregation of self-disorders
(SDs, various anomalies of self-awareness) in schizophre-
nia-spectrum conditions, comparing different diagnostic
groups; 305 subjects, previously assessed in the Copenha-
gen Schizophrenia Linkage Study, were grouped into 4 ex-
perimental samples, according to their Diagnostic and
Statistical Manual of Mental Disorders (Third Edition Re-
vised) main diagnosis: schizophrenia, (n 5 29), schizotypal
personality disorder (n 5 61), other mental illness not be-
longing to the schizophrenia spectrum (n 5 112), and no
mental illness (n 5 103). The effect of diagnostic grouping
on the level of SDs was explored via general linear model
and logistic regression. The diagnosis of schizophrenia and
schizotypy predicted higher levels of SDs, and SDs scores
were significantly different between spectrum and nonspec-
trum samples; the likelihood of experiencing SDs increased
as well with the diagnostic severity. The findings support
the assumption that SDs are a discriminant psychopatho-
logical feature of the schizophrenia spectrum and suggest
their incorporation to strengthen its construct validity, with
potential benefit for both early detection and pathogenetic
research.
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Introduction
Thenotionofselfisabsentinthecurrentdescriptionsand
diagnostic criteria for schizophrenia (International Clas-
sification of Diseases, Tenth Revision [ICD-10], Diagnos-
tic and Statistical Manual of Mental Disorders [Fourth
Edition, Text Revision]). In fact, the notions of self,
self-awareness (self-consciousness), and sense of identity
have largely disappeared from the mainstream psycho-
pathological vocabulary.
This descriptive lacuna is rather mysterious because
profound and various transformations of the sense of
selfhavebeennotedfor longinschizophreniaandits spec-
trum conditions, ie, schizoidia,replaced byschizotypy(for
a detailed review, see Parnas and Handest
1 and Parnas
et al
2). The anomalies of the sense of self were considered
as fundamental or core subjective clinical manifestations
of schizophrenia since its earliest descriptions (see Sass
and Parnas
3 and Parnas and Handest
1). Indeed, the
Kraepelinian metaphor of ‘‘orchestra without a conduc-
tor,’’ which pointed to the ‘‘loss of inner unity’’ of con-
sciousness, was echoed in the writings of nearly all
prominent classic schizophrenia researchers.
4–6
Thus, Bleuler
4 observed that ‘‘the most manifold alter-
ations’’ occurred to the patient’s ego, including splitting
of the self and loss of feeling of agency or of the mastery
to direct thoughts, pointing to a ‘‘basic disorder’’ of per-
sonality. Most notably, however, Berze
5 (an Austrian
psychiatrist) proposed that a subtle alteration of self-
consciousness (‘‘primary insufficiency’’), ie, a peculiar
and pervasive experience of diminished transparency and
affectability of awareness, was the primary disorder of
schizophrenia, a claim that Berze backed up with quite
impressive empirical data. Fine-grained explorations of
the pathology of the self were also performed in phenom-
enological psychiatry.
6–10 However, these contributions
remained virtually unknown on the international stage
and were never referred to in the scientific debate, despite
an arrival of uniquely original Anglophone studies in the
1960s and 1970s.
11–14
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of psychopathology was due to a confluence of factors:
scarcity of translations into English; a mainstream,
one-sided focus on operationally ‘‘objective’’ behavioral
terms (with a corresponding neglect of the subjective);
and a wide-ranging, yet inexplicit or tacit, heuristic im-
poverishment of psychopathology and its concepts to
the level of a subsidiary, descriptive glossary modeled af-
ter diagnostic criteria (see Parnas et al
15 and Andreasen
16
for a comprehensive overview).
The recent revival of psychopathological interest in the
subjective aspects of schizophrenia coincided with an in-
creasing interest in early detection and treatment of the
illness.
17 These efforts exposed an insufficiency of a pure
behavioristic framework and stimulated an increasing in-
ternationalrecognitionofthe workbyHuber,Gross, and
Klosterko ¨tterandtheir successorsinGermany,whohave
been pursuing systematic studies of subjective experience
in schizophrenia for several decades.
18–23 This research
established that anomalous subjective experiences
(ASEs)—which are aberrations of experience of nonpsy-
chotic intensity and quality (ie, nondelusional, nonhallu-
cinatory) in the domain of affect, perception, cognition,
acting,andbody—areimportantandearlyphenotypesof
schizophrenia.
24–31 ASEs are detailed in an interview
schedule, the Bonn Scale for the Assessment of Basic
Symptoms—BSABS
32 (translated and published in Dan-
ish by our group in 1995), and a more recent, abridged
English language version, the Schizophrenia Proneness
Instrument Adult version.
33
Recent years’ growing multicenter empirical evidence
seems to confirm that ASEs occur in various schizophre-
nia-related conditions (ie, full-blown schizophrenia, pro-
dromalconditions,schizotypy,andamongthesubjectsat
high genetic risk)
26–29,34–42
Our own approach—in the continuation of American-
Danish high-risk and adoption studies, and, more recent,
genetic studies
43–48—has been concerned with expressive
and experiential features characteristic of schizophrenia
and schizotypy (‘‘fundamental’’ in Bleuler’s sense or, in
a more contemporarylanguage, core features). We focus-
sed—continuously remaining anchored in clinical
work—on what might considered as an expanded subset
of ASEs (basic symptoms), namely, that of self and its
pathology, such as abnormal self-awareness and self-
experience (SDs = self-disorders). Naturally, the concept
of self (more generic than that of ASEs that are basically
considered as contingent independent symptoms)
requires a psychopathological-phenomenological and
philosophical grounding beyond a lay understanding
1,3
(for detailed epistemological considerations, see Parnas
et al
15). However, in the empirical context, we use the
concept of SDs, not as an inference or some formal con-
struct but as expressing real complaints of real patients:
eg, fear of dissolving or losing first-person perspective,
lack of basic sense of identity, feeling of one’s privacy
ofconsciousnessbecomingcompromisedandsomehowac-
cessible to others, etc. As it is the case with ASEs, we deal
here with lived experiences (‘‘Erlebnisse’’) and not with re-
alityjudgments(thesephenomenaarenotinthemselvesde-
lusional). In a study succeeding the pilot data, we showed
that SDs discriminated between ICD-10 schizophrenia in
remission (elevated levels) compared with psychotic bipo-
lar illness in remission.
36 A prospective longitudinal study
of 155 first-admission cases demonstrated that SDs aggre-
gated selectively among the ICD-10 nonaffective psychotic
patients (mainly schizophrenias) and in the patients with
schizotypal disorders but not in the diagnostic categories
outside the spectrum.
41,42
However,withrespecttothevalidationofSDs as acore
feature ofschizophrenia-spectrum disorders, there are still
several critical drawbacks. First, the results of early detec-
tion studies may be difficult to interpret. For pragmatic
reasons, early detection intervention programs are guided
by a prenosological risk stratification, in which the in-
creasedriskiscompiledasanew,paradiagnosticcategory.
Obviously, the stratification of ‘‘at-risk’’ populations is
actuarially assisted, and the resulting psychopathological
profiles are therefore influenced in by geographically and
culturally determined local referral habits and processes
(service availability, socioeconomic factors, structure of
the health system, who does makes a referral, on which
behavioral criteria, etc). Consequently, the reported tran-
sition rates to schizophrenia may vary quite dramatically
across time and space.
49,50
On the other hand, the studies dealing with explicitly
classifiedclinicalconditions(andthusframedwithinano-
sological schema) suffer from a narrowing of the sam-
pling focus on the full-blown schizophrenic conditions
and a preeminent emphasis on affective disorders as
a preferable control condition. Moreover, the data are
available on patients only, ie, there is no information
on the (untreated) cases of schizophrenia and schizotypal
disorders with no contact to a health system. Further-
more, the shortage of data concerning SDs in schizotypal
disorder (schizotypal personality disorder [SPD]) sam-
plespreventsanyempiricallysupportedinferencewithre-
spect to their relevance for the schizophrenia spectrum.
The current study was undertaken in order to validate
the status of SDs as basic subjective phenotypes of the
schizophrenia-spectrum disorders (schizophrenia and
schizotypy) through an interdiagnostic design. More spe-
cifically, our hypothesis was that the distribution of SDs
will mirror the pattern detected in our sample of 155 first-
admission cases
41: Schizophrenia and SPD would demon-
strate comparable and elevated levels of SDs, significantly
higher than those of other (nonspectrum) diagnostic
groups or of individuals with no psychiatric diagnosis.
SDs’ lifetime prevalence was evaluated across 4
diagnostic groups, ie, schizophrenia, SPD, other mental
illness (OMI), and a control sample without recognizable
clinical psychopathology.
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Participants
The current study explores psychopathological data col-
lected in the Copenhagen Schizophrenia Linkage Study
(CSLS, n = 618; see Matthysse et al
48 and Vaever et al
51).
Thestudywasguidedbyahypothesisthatextendedpedigree
information—comprising phenotypes such as schizotypal
disorder andmarkers suchasThoughtDisorder Index
52,53
and eye tracking dysfunction
54,55 might substantially
contributetomappingtheallelesimplicatedinschizophre-
nia. The study targeted 6 families, each including at least
2affected members with DiagnosticandStatistical Manual
of Mental Disorders (Third Edition Revised) (DSM-III-R)
diagnosis of schizophrenia. The study began in 1989 as an
outgrowth of the Copenhagen High-Risk Study.
47 Each
family was horizontally and vertically extended into
ratherlargepedigrees(ie,familieswithmanysiblings,aunts,
cousins, etc [see genograms in Vaever et al
51]).
All CSLS subjects, who were personally interviewed
(n = 347) and on whom complete psychopathological
data on SDs were available, were included in the current
protocol (n = 305). The sample was divided into 4 diag-
nosticgroupsinordertocomparetheSDsscoresbetween
Axis I (psychotic) schizophrenia-spectrum conditions
(sample 1, schizophrenia), Axis II (nonpsychotic) schizo-
phrenia-spectrum conditions (sample 2, SPD), OMI, not
belonging to the schizophrenia spectrum (sample 3), and
controls with no mental illness (NMI, sample 4). We thus
repeated a diagnostic classification performed in an ear-
lier study on the distribution of SDs among 155 first-ad-
mission cases,
41 a study that inspired the current
investigation. The assignment to sample 1 or sample 2
within the schizophrenia spectrum was based on the pri-
mary lifetime diagnosis representing the most severe di-
agnosis according to DSM-III-R criteria and the relevant
Axis I/Axis II distinction. Hence, subjects with SPD and
concomitant Axis I nonaffective psychotic conditions
were included in group 1.
Diagnostic Groups
Individuals with either an Axis I nonaffective psychotic
diagnosis or an Axis II SPD/schizoid personality disorder
diagnosiswereconsideredtobemembersofthespectrum.
Thus, the ‘‘schizophrenia’’ group in the current study
includes individuals with the following DSM-III-R diag-
noses: (a) schizophrenia (n = 19) and (b) delusional disor-
der, brief reactive psychosis, and psychotic disorder not
elsewhere classified but only with a simultaneous Axis
II diagnosis of SPD (n = 10). The ‘‘SPD’’ group includes
61 individuals with no Axis I diagnosis and SPD as prin-
cipal Axis II diagnosis. The ‘‘OMI’’ group includes any
individual with an Axis I or Axis II diagnosis that was
not in the schizophrenia spectrum (n = 112). The partic-
ipants allocated in this group exhibited a wide variety of
diagnoses, such as affective disorders, alcohol abuse,
andeatingdisorders.Finally,the‘‘NMI’’’’groupincludes
familymemberswithnodiagnosesoneitherAxisIorAxis
II (n = 103). The groups are shown in table 1.
Measures
Psychopathological Assessment. Detailed diagnostic
and psychopathological assessment was performed dur-
ing the CSLS.
51 Two senior clinicians blind to any diag-
nostic information, clues to the kinship status, and the
surnameofthesubjectsadministered theCopenhagenIn-
terview of Functional Illness
56 to all the enrolled partic-
ipants. The Copenhagen Interview of Functional Illness
is an extensive semistructured diagnostic interview com-
posed of a compilation of existing psychiatric question-
naires (Danish versions), as well as additional items that
were either theoretically motivated or influenced by our
experience in the original high-risk study. The interview
contained the psychosis section from the Present State
Examination, 10th edition
57; an abbreviated Personality
Disorder Examination (PDE)
58; the Thought, Language,
andCommunicationScale
59;ScalesfortheAssessmentof
Positive and Negative Symptoms
60,61; Schedule for Af-
fective Disorder and Schizophrenia—Life Time Version
Table 1. Characteristics of the Study Sample
Participants Schizophrenia
Schizotypal
Personality
Disorder
Other
Mental
Illness No Mental Illness Statistic
N 305 29 61 112 103
Gender
Male/female ratio 141/164 5/24 29/32 50/62 57/46 v
2 = 13.40 (P = .004)
% Male 46.2 17.2 47.5 44.6 55.3
Age, y
Mean 41.1 43.6 36.4 39.4 45.2 F (Welch) = 4.34 (P = .006)
SD 16.6 18.9 14.7 15.0 17.8
Duration of illness, y
Mean — 15.5 21.5 18.3 — F (Welch) = 1.44 (P = .247)
SD — 13.4 14.7 14.3 —
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62; a list of
basic symptoms corresponding to sections C and D from
the BSABS
32; and single interview items used in the
Copenhagen adoption and high-risk studies.
45,46
Diagnosis. DSM-III-R ‘‘lifetime’’ psychiatric diagnoses
of each participant were determined by the consensus
among 4 research psychiatrists/psychologists using all
the available data sources. Interrater diagnostic reliabil-
ity was assessed and prevented from drift via group inter-
view sessions (interviews conducted by J.P.). The mean
interrater reliability ranged between 0.900 and 0.956,
similar to that reported in Parnas et al.
47
SDs Score. An SDs Scale was generated a priori to pick
up the anomalies of subjective experience, that relate both
empirically
41 and theoretically,
1,3 to a disturbed sense of
coreselfinitsmanifoldexpressions(disordersofself-aware-
ness or self-experience). The specific scale items (especially
t h o s ef r o mP D Ea n dB S A B S )w e r et h u ss e l e c t e do nt h eb a -
sis of their phenomenological affinity with the characteris-
tic, not yet psychotic, morbid self-experiences that we have
been investigating, clinically, for many years and, empiri-
cally, in recent studies.
36,41 In phenomenological terms,
these experiences point to a diminished sense of being
a self-coinciding pole of identity, spontaneity, and agency
and encompass the decrease in first personal aspects of
mental contents (which become more anonymous), the de-
crease of fluidity and transparency of the stream of con-
sciousness, and a difficulty in world immersion and in
the natural grasping of previously familiar meanings. Typ-
ical subjective reports are ‘‘I never feel fully awake, it is as if
my head is constantly filled with a fog,’’ ‘‘It feels as if my
point of view on the world sometimes shifts few centimetres
backwards,’’ ‘‘I have to constantly monitor my thoughts,’’
‘‘Thinkingissimplygoingoninmyhead,withmeasaspec-
tator,’’ and ‘‘During a conversation, I lose the sense of
whosethoughtsinitiateinwhom.’’Detailedclinicaldescrip-
tions with verbatim quotations are provided elsewhere (see
Parnas and Handest
1 and Parnas et al
2).
The items were originally coded as 0 (not present), 1
(doubtfullypresent),or2(definitelypresent).However,be-
cause the majority of the participants only received scores
0or2, thescore of 1was recoded into 0(notpresent) and 2
redefinedas1(present),arecodingperformedforallitems.
Detailed composition of the SDs Scale is shown in Ap-
pendix 1. Its a coefficient
63 of internal coherence was at
a very good level and reaffirmed a required dimensional-
ity. Removing any single item from the scale would not
substantially increase the a coefficient. The SDs score for
each subject was calculated as a sum of ratings of the in-
dividual scale items (which had values 0 or 1).
Data Analyses
We explored the sociodemographic features of the sam-
ples using v
2 test for categorical variables and Welch
weighted analysis of variance for continuous variables.
To estimate the effect of diagnostic grouping on SDs
score, we used the analysis of covariance (general linear
model [GLM] procedure in SPSS). In a second step—
with the logistic regression—we analyzed the predictive
power of the adjusted model with respect to the pres-
ence/absence of SDs as outcome variable.
Results
The demographic features of the 4 experimental samples
are presented in table 1. The groups differ with respect to
sex distribution and mean age, whereas there is no signif-
icant difference of the duration of the illness among the
clinical subsamples (ie, schizophrenia, SPD, OMI).
The GLM with SDs score as outcome measure, clinical
groupingasfixedfactor,andgenderandageascovariates
is presented in table 2. The GLM reveals a significantly
different effect of the 4 clinical groups on the SDs score.
Among the demographic covariates, age has a significant
negative association with SDs.
Post hoc analysis (Bonferroni bounds–adjusted paired
multiple comparisons between all the 4 levels of the factor
clinical grouping) confirmed significant differences be-
tween spectrum vs nonspectrum samples: schizophrenia =
SPD > OMI = NMI.
The logistic regression model, predicting the presence
or absence of SDs as outcome variable, showed good fit
(goodness-of-fit test, v
2 = 80.4, df = 5, P < .0001) and
a Nagelkerke approximation of R
2 of 0.31. Table 3 shows
that the more the diagnosis is severe with respect to the
schizophrenia spectrum, the higher is the odds ratio for
SDs. Specifically, given NMI as reference group, the
chances of experiencing at least one symptom of the
SDs Scale are almost 3 times higher in OMI, 11 times
higher in SPD, and 21 times higher in schizophrenia.
Table 2. General Linear Model: Effects of Diagnosis on Self-
disorders Score
B 95% CI SE tP
Diagnosis
Schizophrenia 5.60 4.06 to 7.15 0.79 7.13 <.001
SPD 4.20 3.01 to 5.38 0.60 6.97 <.001
OMI 1.20 0.21 to 2.20 0.51 2.38 .018
NMI
a —— — — —
Sociodemographic
covariates
Age, y  0.04  0.06 to  0.01 0.01  2.77 .006
Sex (female)
b 0.70  0.14 to 1.55 0.43 1.64 .102
Note: CI, confidence interval; SPD, schizotypal personality
disorder; OMI, other mental illness; NMI, no mental illness.
Bonferroni bounds–adjusted paired multiple comparisons:
schizophrenia, SPD > OMI, NMI.
aReference category.
bMale as reference category for sex.
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the GLM—but with a relatively small effect on the odds
ratio per each unit increase.
Discussion
Our findings confirm that subjects with a schizophrenia-
spectrum diagnosis exhibit higher degrees of qualitatively
ASE (SDs) when compared with clinical nonspectrum
samples and with healthy controls. Thus, the SDs seem
to express a potentially important trait phenotype for
the clinical characterizationof the schizophrenia spectrum.
Furthermore, our findings suggest that schizophrenia
and SPD share comparable levels of nonpsychotic experi-
ential anomalies and thus confirm a similar, previously
reported pattern observed among 155 first-admission
patients with spectrum and nonspectrum diagnoses.
41
This similarity provides an additional validity to the schiz-
otypal disorders as belonging tothe schizophrenic spectrum
and strengthens the conceptual salience of nonpsychotic
anomalies of self-experience for the construct validity of
the schizophrenia-spectrum notion. Indeed, the anomalies
of self-experience, once explicitly considered of intrinsic rel-
evance for the diagnosis and a comprehensive grasp of
schizophrenia gestalt,
5,6,64–66 sank into oblivion with the
construction of contemporary diagnostic criteria, yielding
to overriding concerns about reliability and a generally be-
havioristic bent of psychopathology.
15
Moreover, recent empirical work has rediscovered
these phenomena, emphasizing anomalies of subjective
experience as a fundamental, generative feature of
symptomatology of schizophrenia-spectrum
conditions.
1,3,34–36,67,68 This aspect is of substantial
importance for the issues of early identification of sub-
jects at risk of transition to psychosis. Indeed, nonpsy-
chotic disorders of subjectivity are increasingly
acknowledgedaspotentiallyusefulclinicaltargetfeatures
forthepurposeofearlydetection,particularlyasawayto
supplement the ultrahigh risk identification approach
(based on the notion of attenuated or intermittent psy-
chotic symptoms).
17,31,69
In this respect, it seems to us that SDs are mainly etio-
logically informative as early markers of clinical vulnera-
bility but whose specificity is constituted or articulated
through their position in a certain characteristic psycho-
pathological gestalt. Therefore—to be of any clinical
and heuristic use—SDs should not be considered (and
assessed) as a contingent aggregate of otherwise mutually
independent, atomized, and decomposable anomalous
features/experiences but precisely as a coherent psycho-
pathological structure indicative of a profound distortion
of subjectivity as a whole.
1–3 Also—given the peculiar na-
ture of our experimental sample (ie, individuals at familial
risk for schizophrenia-spectrum disorders)—the sort of
vulnerability subtended by SDs might be more pertinently
conceived as a broad vulnerability to the development of
schizophrenia-spectrum conditions (ie, a ‘‘spectrum
proneness’’ encompassing both psychotic and nonpsy-
chotic conditions such as SPD), rather than as a more spe-
cific proneness toward the development of psychosis
(defined in terms of full-blown psychotic symptoms) as
such; therefore, the primary relevance of SDs would be
in terms of etiological research in the genetic architecture
of schizophrenia, and, only secondarily, it could serve as
further marker of lifetime risk of psychosis.
Somelimitationsofthecurrentstudyneedtobetakenin
account in interpreting the results. First, we use data col-
lectedintheCSLS.Thelatterincludedparticipantsbelong-
ing to extended family pedigrees of probands with
adiagnosisofDSM-III-Rschizophrenia.Theexperimental
sample is therefore by definition representative of a genet-
ically high-risk population for the development of schizo-
phrenia-spectrum disorders. However, this feature should
reduce,rather thanamplify, the quantitativedifferences in
SDsacrossthediagnosticcategories.Second,giventhecir-
cumscribedhypothesistestingofthecurrentstudy,whichis
not addressing/endorsing any specific genetic model of
schizophrenia,weabstainedfromusingthepositionofsub-
jectsinthegenograms.Indeed,asimplestratification(first
degree,seconddegree,etc)wouldnotworkduetothecom-
plexityofthepedigrees.Wealsorefrainedfromapplyingan
algorithmforatotalcomputationofeachfamilymember’s
truegeneticvulnerabilitybytakingintoaccounthisunique
position in the genogram and hence all his affected rela-
tives, close and distant (see Lawrie et al
70).
Third, the assessment of SDs was performed by aggre-
gating available psychopathological items (see Appendix
1), which does not exhaust the clinical richness, manifold
andvaryingarticulationofthedisordersofself-awareness,
as recently described in the Examination of Anomalous
Self-experience scale.
1–3 Finally, our assessments address
only the lifetime prevalence of SDs, with no information
concerning their degree of intrusiveness, pervasiveness,
frequency, and temporal coaggregation, information that
could be relevant for further distinctions into differential
Table 3. Logistic Regression Model with Absence/Presence of
Self-disorders as Outcome Variable
Odds
Ratio
95%
Conﬁdence
Interval P
Diagnosis
Schizophrenia 20.97 6.82 to 64.46 <.001
Schizotypal personality
disorder
11.12 5.14 to 24.06 <.001
Other mental illness 2.60 1.38 to 4.87 .003
No mental illness
a 1— <.001
Sociodemographics
Age, y 0.98 0.96 to 0.99 .004
Sex (female)
b 1.10 0.65 to 1.87 .722
aReference category.
bMale as reference category for sex.
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tions. In a broader research perspective, it is to be pointed
outthatthe studyisbasedonapopulationsample,w h i c hi s
mainly nonclinical and only diagnosed in the contexts of
a genetic research protocol. Thus, the diagnoses are inde-
pendent of any contact with treatment facilities (and, eg,
chronicity), and the clinical expressivity is not confounded
by psychopharmacologic and other treatments.
In this respect, the results (1) confirm and further gen-
eralizetheschizophreniaspectrumdiscriminatingdiagnos-
tic power of SDs, previously reported within clinical
samples
36,41,42 and (2) prompt a promising phenotypical
model suitable for further testing in the genetic research
on the architecture of the vulnerability to schizophrenia.
Conclusion
In summary, the data point to an overall specific aggre-
gation of SDs in schizophrenia-spectrum conditions and
corroborate the internal coherence of the schizophrenia
spectrum across DSM-III-R (and following versions)
Axis I and Axis II. Indeed, elevated levels of nonpsy-
chotic anomalies of subjective experience characterize
both schizophrenia and SPD groups and distinguish
them from nonspectrum clinical (ie, OMI) and nonclin-
ical (ie, NMI) conditions.
Besides the implication for the validity of the schizo-
phrenia-spectrum construct, the results further confirm
the clinical importance of experiential anomalies for re-
fining the identification of spectrum phenotypes both in
early detection and in genetic research. Finally, the study
provides the rational background for further investiga-
tionofSDsasadimensionaltrait,potentiallyinformative
ofthetransgenerational latentvulnerabilitytotheschizo-
phrenia-spectrum disorders.
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